Delphine Déniel1,2,*, Fabienne Le Goc-Le Sager1, Paul Touchard3, Véronique Marty4, Laurence Hasle5, Véronique Jestin Le Tallec6, Monique Jegaden7, Annaïk Pestel8, Virginie Jannou5, Sophie Pentecôte9, Laurence Guen1,2, Christophe Perrin1,10, Sandrine Estivin1,3
Oncologie, Vol.23, No.4, pp. 453-461, 2021, DOI:10.32604/oncologie.2021.019964
Abstract Context: Since January 2021, vaccination for COVID-19 has been made possible in France for people aged 75 and
over. Patients suffering from a cancer disease are part of a group at risk to develop severe complications to
COVID-19. Method: The « Unité de coordination en Onco-Gériatrie région Bretagne » (the Brittany
This work is licensed under a Creative Commons Attribution 4.0 International License, which
permits unrestricted use, distribution, and reproduction in any medium, provided the original
work is properly cited.
Coordinating Unit in Onco-Geriatrics) has wished to set up an inquest about the acceptability and the tolerance to
COVID-19 vaccination… More >